Abd Alrahman Benni, MD
Anesthesiology · Brandon, FLNPI 1568439701
Payments from drug & device makers
Across 251 payments — averaging $18.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$434
- Teva Pharmaceuticals USA, Inc.$265
- Pfizer$256
- Abbott$249
- Daiichi Sankyo Inc.$231
- plus $2K from 27 others
Across 1 payment — averaging $600.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Philips North America LLC$600
What the payments were for
- Travel & lodging$251%
- Food & beverage$4,58099%
- Education$210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 90 | $1,494 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 23 | $434 |
| Teva Pharmaceuticals USA, Inc. | 16 | $265 |
| Pfizer | 20 | $256 |
| Abbott | 10 | $249 |
| Daiichi Sankyo Inc. | 11 | $231 |
| Orexo US, Inc. | 12 | $205 |
| Redhill Biopharma Inc. | 5 | $203 |
| Indivior Inc. | 8 | $176 |
| Scilex Pharmaceuticals Inc. | 10 | $173 |
| AbbVie | 6 | $127 |
| Sanofi-aventis U.S. LLC | 1 | $118 |
| Protega Pharmaceutials Inc | 5 | $91 |
| Amgen | 5 | $90 |
| Zyla Life Sciences, Inc. | 4 | $65 |
| Lilly USA, LLC | 3 | $51 |
| AstraZeneca | 3 | $48 |
| Zimmer Biomet | 1 | $38 |
| Hikma Pharmaceuticals USA | 2 | $35 |
| Boston Scientific | 2 | $33 |
| Biohaven Pharmaceuticals, Inc. | 2 | $31 |
| Novartis | 1 | $23 |
| Vertos Medical, Inc. | 1 | $23 |
| Curonix LLC | 1 | $22 |
| Valinor Pharma, LLC | 1 | $21 |
| Bioventus LLC | 1 | $21 |
| Ambu Inc. | 1 | $17 |
| Medtronic | 1 | $16 |
| Shionogi Inc | 1 | $16 |
| Exact Sciences | 1 | $16 |
| Pernix Therapeutics Holdings, Inc. | 1 | $13 |
| Fidia Pharma USA Inc. | 1 | $12 |
| Forte Bio-pharma LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MOVANTIK$136
- TZIELD$118
- Morphabond ER$117
How this compares
$4,626 in reported general payments places this provider in the 95th percentile of 2,767 anesthesiology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 407 | $350,904 |
| OxycontinOxycodone Hcl | 123 | $86,549 |
| Oxycodone Hcl | 2,190 | $60,016 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,092 | $49,126 |
| Morphine Sulfate ErMorphine Sulfate | 873 | $41,983 |
| MovantikNaloxegol Oxalate | 94 | $38,709 |
| RelistorMethylnaltrexone Bromide | 12 | $26,861 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 114 | $24,254 |
| Fentanyl | 119 | $20,907 |
| Hydromorphone Hcl | 323 | $16,054 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 453 | $14,588 |
| Oxymorphone Hcl ErOxymorphone Hcl | 25 | $14,328 |
| ZtlidoLidocaine | 33 | $10,721 |
| Methadone Hcl | 338 | $8,366 |
| Hysingla ErHydrocodone Bitartrate | 22 | $8,352 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $1,494 | $350,904407 claims |
| Redhill Biopharma Inc.Movantik | $203 | $38,70994 claims |
| Hikma Pharmaceuticals USABuprenorphine-Naloxone, Morphine Sulfate | $35 | $30,701257 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $434 | $26,86112 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $173 | $10,72133 claims |
| Indivior Inc.Suboxone | $176 | $7,41513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,767 anesthesiology providers in Florida.
Other anesthesiology in Brandon
- Brandon LenoxMaitland$31.9M
- Lisa PatelLutz$6.5M
- Alfredo FernandezMiami$3.8M
- Rene PrzkoraGainesville$650K
- Andrea EschGainesville$632K
- Danielle HornMiami$462K
- Robert LondonOrlando$402K
- Ralf GebhardMiami$393K
- Klaus TorpJacksonville$387K
- Todd JonesGainesville$298K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.